Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3

• Published in: Clinical and experimental immunology 2022-12, Vol.210 (3), p.309-320
• Main Authors: Wu, Xu, Zhang, Hui, Jiang, Gang, Peng, Minlian, Li, Cheng, Lu, Jiaxin, Jiang, Shiyin, Yang, Xiaoping, Jiang, Yongliang
• Format: Article
• Language: English
• Subjects: B7-H1 Antigen - metabolism; Cancer Immunity; Carcinoma, Non-Small-Cell Lung - pathology; Cell Line, Tumor; Cell Movement; Cell Proliferation; Exosomes - metabolism; Humans; Immunosuppression Therapy; Lung Neoplasms - pathology; S100 Calcium-Binding Protein A4 - metabolism; S100 Calcium-Binding Protein A4 - pharmacology; STAT3 Transcription Factor - metabolism
• ISSN: 0009-9104; 1365-2249
• DOI: 10.1093/cei/uxac102

Non-small cell lung cancer (NSCLC) is the primary reason of tumor morbidity and mortality worldwide. We aimed to study the transfer process of S100A4 between cells and whether it affected NSCLC development by affecting STAT3 expression. First, S100A4 expression in NSCLC cells was measured. The exosomes in MRC-5, A549, and H1299 cells were isolated and identified. We constructed si-S100A4 and si-PD-L1 to transfect A549 cells and oe-S100A4 to transfect H1299 cells, and tested the transfection efficiency. Cell function experiments were performed to assess cell proliferation, clone number, apoptosis, cell cycle, migration, and invasion abilities. In addition, ChIP was applied to determine the targeting relationship between S100A4 and STAT3. Next, we explored NSCLC cell-derived exosomes role in NSCLC progress by transmitting S100A4. Finally, we verified the function of exosome-transmitted S100A4 in NSCLC in vivo. High expression of S100A4 was secreted by exosomes. After knocking down S100A4, cell proliferation ability was decreased, clones number was decreased, apoptosis was increased, G1 phase was increased, S phase was repressed, and migration and invasion abilities were also decreased. ChIP validated STAT3 and PD-L1 interaction. After knocking down S100A4, PD-L1 expression was decreased, while ov-STAT3 reversed the effect of S100A4 on PD-L1 expression. Meanwhile, S100A4 inhibited T-cell immune activity by activating STAT3. In addition, knockdown of PD-L1 inhibited cell proliferation, migration, and invasion. NSCLC cell-derived exosomes promoted cancer progression by transmitting S100A4 to activate STAT3 pathway. Finally, in vivo experiments further verified that exosome-transmitted S100A4 promoted NSCLC progression. Exosome-transmitted S100A4 induces immunosuppression and the development of NSCLC by activating STAT3.